As our understanding of pancreatic cancer evolves, evidence is growing to support a role for cancer stem cells in this devastating disease. Cancer stem cells constitute a distinct subpopulation in the tumor and are considered to drive both tumorigenesis and metastasis; these cells are thought to be highly resistant to standard treatment modalities. Here we review the current knowledge on pancreatic cancer stem cells and the implementation of cancer stem cell markers as prognostic or predictive biomarkers. We also discuss prospects for the use of cancer stem cells as targets for future therapeutic regimens in pancreatic cancer.status: publishe
Metastasis and tumor progression are the major cause of death in patients suffering from pancreatic ...
The ever-growing perception of cancer stem cells (CSCs) as a plastic state rather than a hardwired d...
Pancreatic cancer has the worst prognosis of any major malignancy, with an annual death rate that ap...
Pancreatic cancer continues to be a malignancy with few therapeutic options. The majority of patient...
The discovery of stem cells and their potential abilities in self-renewal and differentiation has op...
Pancreatic cancer has the worst prognosis of any major malignancy, with an annual death rate that ap...
SummaryPancreatic adenocarcinoma is currently the fourth leading cause for cancer-related mortality....
This article belongs to the Special Issue Latest Development in Pancreatic Cancer.Pancreatic ductal ...
Cancer stem cells (CSCs) have been identified as a subpopulation of stem-like cancer cells with the ...
Pancreatic adenocarcinoma is currently the fourth leading cause for cancer-related mortality. Stem c...
AbstractThe terms cancer-initiating or cancer stem cells have been the subject of great interest in ...
Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignancy. Existing ...
[[abstract]]Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignanc...
[[abstract]]Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignanc...
[[abstract]]Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignanc...
Metastasis and tumor progression are the major cause of death in patients suffering from pancreatic ...
The ever-growing perception of cancer stem cells (CSCs) as a plastic state rather than a hardwired d...
Pancreatic cancer has the worst prognosis of any major malignancy, with an annual death rate that ap...
Pancreatic cancer continues to be a malignancy with few therapeutic options. The majority of patient...
The discovery of stem cells and their potential abilities in self-renewal and differentiation has op...
Pancreatic cancer has the worst prognosis of any major malignancy, with an annual death rate that ap...
SummaryPancreatic adenocarcinoma is currently the fourth leading cause for cancer-related mortality....
This article belongs to the Special Issue Latest Development in Pancreatic Cancer.Pancreatic ductal ...
Cancer stem cells (CSCs) have been identified as a subpopulation of stem-like cancer cells with the ...
Pancreatic adenocarcinoma is currently the fourth leading cause for cancer-related mortality. Stem c...
AbstractThe terms cancer-initiating or cancer stem cells have been the subject of great interest in ...
Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignancy. Existing ...
[[abstract]]Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignanc...
[[abstract]]Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignanc...
[[abstract]]Pancreatic ductal adenocarcinoma (PDAC) is a devastating and highly aggressive malignanc...
Metastasis and tumor progression are the major cause of death in patients suffering from pancreatic ...
The ever-growing perception of cancer stem cells (CSCs) as a plastic state rather than a hardwired d...
Pancreatic cancer has the worst prognosis of any major malignancy, with an annual death rate that ap...